These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8745031)

  • 1. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome.
    Borgna-Pignatti C; Bezzi TM; Reverberi R
    Pediatr Infect Dis J; 1995 Dec; 14(12):1116-7. PubMed ID: 8745031
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection.
    Moallem HJ; Garratty G; Wakeham M; Dial S; Oligario A; Gondi A; Rao SP; Fikrig S
    J Pediatr; 1998 Aug; 133(2):279-81. PubMed ID: 9709722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia.
    Viner Y; Hashkes PJ; Yakubova R; Segal-Kupershmit D; Luder AS
    Pediatr Infect Dis J; 2000 Jan; 19(1):83-5. PubMed ID: 10643859
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis.
    Liu W; Yu D
    Pediatr Allergy Immunol; 2014 Feb; 25(1):101-2. PubMed ID: 24118095
    [No Abstract]   [Full Text] [Related]  

  • 6. Ceftriaxone associated hemolysis.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 1999 May; 111(9):368-70. PubMed ID: 10407998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal hemolysis caused by ceftriaxone.
    Lascari AD; Amyot K
    J Pediatr; 1995 May; 126(5 Pt 1):816-7. PubMed ID: 7752013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
    Imam SN; Wright K; Bhoopalam N; Choudhury A
    J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone-induced haemolytic anaemia in a child with no immune deficiency or haematological disease.
    Citak A; Garratty G; Ucsel R; Karabocuoglu M; Uzel N
    J Paediatr Child Health; 2002 Apr; 38(2):209-10. PubMed ID: 12031011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuterol-induced myocardial ischemia in sickle cell anemia after hemolysis from ceftriaxone administration.
    Corso M; Ravindranath TM
    Pediatr Emerg Care; 2005 Feb; 21(2):99-101. PubMed ID: 15699818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
    File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley I; Thye D
    Clin Infect Dis; 2010 Dec; 51(12):1395-405. PubMed ID: 21067350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and fatal cephalosporin-induced autoimmune haemolytic anaemia.
    Boilève A; Gavaud A; Grignano E; Franck N; Carlotti A; Mira JP; Bouscary D; Jozwiak M
    Br J Clin Pharmacol; 2021 Apr; 87(4):2152-2156. PubMed ID: 33075171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone.
    Cannavino CR; Nemeth A; Korczowski B; Bradley JS; O'Neal T; Jandourek A; Friedland HD; Kaplan SL
    Pediatr Infect Dis J; 2016 Jul; 35(7):752-9. PubMed ID: 27093162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature.
    Seltsam A; Salama A
    Intensive Care Med; 2000 Sep; 26(9):1390-4. PubMed ID: 11089773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Jürgens H
    Antibiot Chemother (1971); 2000; 50():47-58. PubMed ID: 10874454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.